Skip to main content

Juan José Palmí Perales

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Juan José Palmí Perales

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Related news

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Over the course of two days, experts presented the latest advances in vectors, different gene modification techniques and their transfer to clinical practice.

Related professionals

Angela Garcia Mogollon

Angela Garcia Mogollon

Unidad de Proyectos Post-Award
Competitive Research Directorate
Read more
María Viñas I Casas

María Viñas I Casas

Predoctoral researcher
Protein kinases in cancer research
Read more
Alvaro Calabuig Goena

Alvaro Calabuig Goena

Postdoctoral researcher
Cardiovascular Diseases
Read more
Adriana Palom Agusti

Adriana Palom Agusti

Postdoctoral researcher
Liver Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.